Acne mRNA vaccine

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

25 competitors in Acne

#DrugCompanyPhaseTrials

1

Aldactone

Pfizer

Approved

12

Acanya

Pfizer

Approved

—3

Niacor

AbbVie

Approved

—4

Levulan

Sun Pharmaceutical Industries, Inc.

Approved

—5

Rogaine

Pfizer

Approved

—6

Medrol

Pfizer

Approved

—7

Otezla

Amgen

Approved

—8

Accutane

CConrado Roberto Hoffmann Filho

Approved

49

Epidiolex

Jazz Pharmaceuticals

Approved

—10

Doryx

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

2Show 16 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Acne3 trials

A Phase 1/2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of an Acne mRNA Vaccine Candidate in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne

Not yet recruiting·Sanofi·Phase 2·NCT07756957·410 enrolled

A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age

Recruiting·Sanofi·Preclinical·NCT06316297·800 enrolled

A Phase 1/2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Participants With Mild Acne

Recruiting·Sanofi·Preclinical·NCT07013747·228 enrolled

Details

Drug Info

Related News